Luye Pharma Group's market cap is currently ―. The company's EPS TTM is $0.019; its P/E ratio is 16.93; Luye Pharma Group is scheduled to report earnings on August 28, 2024, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Jun 22	Dec 21	Jun 21	Dec 20	Jun 20
Income Statement	-
Total Revenue	-	-	-	-	-
Gross Profit	-	-	-	-	-
EBIT	-	-	-	-	-
EBITDA	-	-	-	-	-
Net Income Common Stockholders	-	-	-	-	-
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	¥ 5.57B	¥ 5.51B	¥ 6.34B	¥ 5.41B	¥ 5.36B
Total Assets	¥ 22.57B	¥ 22.58B	¥ 21.84B	¥ 20.63B	¥ 19.56B
Total Debt	¥ 9.19B	¥ 9.49B	¥ 8.91B	¥ 9.98B	¥ 8.99B
Net Debt	¥ 3.62B	¥ 3.98B	¥ 2.56B	¥ 4.58B	¥ 3.63B
Total Liabilities	¥ 13.12B	¥ 13.47B	¥ 12.15B	¥ 12.53B	¥ 11.74B
Stockholders Equity	¥ 8.81B	¥ 8.49B	¥ 9.14B	¥ 7.89B	¥ 7.67B
Cash Flow	-
Free Cash Flow	-	-	-	-	-
Operating Cash Flow	-	-	-	-	-
Investing Cash Flow	-	-	-	-	-
Financing Cash Flow	-	-	-	-	-

Currency in CNY

Luye Pharma Group Earnings and Revenue History

Income Statement >

Luye Pharma Group Debt to Assets

Balance Sheet >

Luye Pharma Group Cash Flow

Cash Flow >

Luye Pharma Group Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing